Medidata Solutions Unveils Program to Recognize Clinical Trial Technology Partners

Medidata Solutions Unveils Program to Recognize Clinical Trial Technology Partners

New Initiative Designed to Boost Collaborative Innovation among Leading Solution Providers to Advance Interoperability across Clinical Trial Systems


NEW YORK - June 22, 2009 - Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced the Medidata Technology Partner Program, a new program designed to advance interoperability and data sharing across clinical trial technologies. The program recognizes technology vendors, contract research organizations (CROs) and other organizations that offer solutions that support data sharing with Medidata products, including the Medidata Rave® platform, in order to streamline and enhance the end-to-end eClinical process.


Designed to support the industry's use of innovative eClinical solutions to manage clinical trial processes, Medidata's Technology Partner Program acknowledges solution providers that use Medidata products-including the standards-based, open architecture of Medidata Rave, an industry-leading electronic data capture, management and reporting solution-for data sharing with other platforms.


The program follows a series of related initiatives introduced by Medidata over the past year intended to drive collaboration among clinical technology providers with interest in building integrations with Medidata Rave. These include Medidata Developer Central, an online community that supports developers' efforts to integrate clinical trial solutions with Medidata Rave, and Medidata Rave Web Services API, a Clinical Data Interchange Standards Consortium (CDISC)-compliant tool designed to facilitate rapid integrations with Medidata Rave for real-time data sharing using data standards.


This program evolved from a number of clinical technology integrations that Medidata Rave customers have used over the last few years. Medidata's Technology Partner Program is designed to acknowledge data-sharing solutions built with Medidata's range of integration tools and approaches, and in particular will draw from the Developer Central community.


Similar to Medidata's ASPire to Win® accreditation program for CROs and other service providers, the Technology Partner Program will formally recognize solution providers that share Medidata's vision of clinical systems interoperability based on industry standards. Medidata today welcomes an initial group of solution providers as Medidata Technology Partners for the integration of the following technologies with Medidata Rave:

 

Almac Clinical Technologies - IXRSTM, an integrated interactive voice and Web response (IVR/IWR) system
CRF Health - TrialMax® eDiary system
invivodata - DiaryPRO® eDiary system
PHT - LogPad® eDiary system
SAS® - SAS Drug Development clinical data repository
United BioSource Corporation - IVR/IWR system

"A narrow, single-vendor approach presents obstacles in today's complex clinical research environment. Sponsors and CROs continue to rely on their choice of technologies like Medidata Rave that work with other systems and help them to achieve their clinical development goals," said Glen de Vries, President, Medidata Solutions. "Our new Technology Partner Program is designed to lay the foundation for industry-wide collaboration and innovation, and Medidata remains committed to partnering with other industry leaders to allow customers to flexibly build an optimal eClinical environment."


For more information on the Medidata Technology Partner Program, please visit http://www.mdsol.com/partnerships/technology.htm and Medidata's booth (#701) at the 2009 DIA Annual Meeting in San Diego, Calif., June 21-25.


About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata DesignerTM), investigator benchmarking and budgeting (Medidata Grants ManagerTM), contract research organization (CRO) benchmarking and budgeting (Medidata CRO ContractorTM), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave®). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies.

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.